Hysterectomy After Endometrial Ablation

On-Demand Webinar
HCP Resources Page
image
Description
Delve into the critical examination of endometrial ablation and its long-term outcomes in this informative webinar featuring Dr. Jim Greenberg and Dr. Barbara Levy. The session scrutinizes the effectiveness of endometrial ablation in managing menstrual bleeding, discussing the concerning rates of hysterectomy following the procedure, potential complications, and the evolving landscape of treatment options. The webinar is essential for healthcare professionals seeking a deeper understanding of the complexities surrounding endometrial ablation, patient satisfaction, and the pursuit of more effective, less invasive alternatives.

Key Takeaways
 
  1. Reevaluation of Endometrial Ablation Effectiveness: The webinar highlights concerns about the high rates of hysterectomy following endometrial ablation, questioning its long-term effectiveness. It delves into the FDA's evolving indications for endometrial ablation devices and the need for a more nuanced understanding of patient selection and expected outcomes.
  2. Understanding Complications and Setting Realistic Goals: The discussion emphasizes the complexities and potential complications post-ablation, such as scarring, adhesions, and difficulties in evaluating the uterine cavity. It also challenges the focus on achieving amenorrhea, advocating instead for a goal of returning patients to normal, acceptable menses.
  3. Exploring Alternatives and Long-term Patient Satisfaction: The webinar underscores the importance of considering alternative treatments like cryotherapy. It stresses the need for healthcare providers to prioritize patient satisfaction and long-term well-being, keeping abreast of new technologies and treatment modalities that align with these goals.
Complete the Form Below to View
Now Playing
Video Library
Barbara Levy, MD moderates a discussion with Geoffrey Bowers, MD and Leslie Hansen Lindner, MD on their insights on the evolution of endometrial ablation and how innovations in cryotherapy may reshape thinking around heavy menstrual bleeding treatment.
A compilation of physician perspectives on the treatment of heavy menstrual bleeding and the Cerene Cryotherapy Device. (4 minutes)
Barbara Levy, MD discusses the treatment of heavy menstrual bleeding and the Cerene Cryotherapy Device. (4 minutes)
James Greenberg, MD and Barbara Levy, MD discuss the implications from recent and historical publications on the rates of hysterectomy after an endometrial ablation.
James Coad, MD and Andrew Brill, MD discuss the science and benefits of cryotherapy for endometrial ablation.
Barbara Levy, MD and Todd Rumsey, MD discuss patient selection criteria for the Cerene Cryotherapy Device (27 minutes).
Barbara Levy, MD along with panelists Robert Rubino, MD, Richard Salter, MD, and Shannon Smith, MD provide insights into the management of menorrhagia. (59 minutes)
Barbara Levy, MD and Gerard Reilly, MD discuss how new innovations in cryotherapy are transforming the treatment of heavy menstrual bleeding. (45 minutes)

Important Safety Information

Cerene® Cryotherapy Device is indicated to ablate the endometrial lining of the uterus in premenopausal women with heavy menstrual bleeding due to benign causes for whom childbearing is complete. Pregnancy following the Cerene procedure can be dangerous; therefore, contraception must be used until menopause. The Cerene procedure is not for those who have or suspect uterine cancer; have an active genital, urinary or pelvic infection; or an IUD. As with all surgical procedures, there are risks and considerations associated with the use of the Cerene Cryotherapy Device. Temporary side effects may include cramping, nausea, vomiting, vaginal discharge and spotting. For detailed benefit and risk information, consult the Cerene Instructions for use (IFU) or your healthcare professional. Learn More